Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 17 04:00PM ET
133.50
Dollar change
-2.56
Percentage change
-1.88
%
IndexS&P 500 P/E31.54 EPS (ttm)4.23 Insider Own0.42% Shs Outstand292.12M Perf Week5.06%
Market Cap38.95B Forward P/E23.34 EPS next Y5.72 Insider Trans-6.17% Shs Float290.54M Perf Month2.81%
Income1.24B PEG6.37 EPS next Q1.26 Inst Own92.43% Short Float1.43% Perf Quarter-2.41%
Sales6.59B P/S5.91 EPS this Y-4.29% Inst Trans-3.30% Short Ratio2.08 Perf Half Y2.28%
Book/sh21.31 P/B6.26 EPS next Y9.87% ROA11.47% Short Interest4.15M Perf Year12.90%
Cash/sh5.73 P/C23.31 EPS next 5Y4.95% ROE20.71% 52W Range96.80 - 155.35 Perf YTD-3.98%
Dividend Est.0.94 (0.71%) P/FCF25.33 EPS past 5Y33.93% ROI14.58% 52W High-14.07% Beta1.05
Dividend TTM0.93 (0.70%) Quick Ratio1.64 Sales past 5Y7.00% Gross Margin54.65% 52W Low37.91% ATR (14)2.96
Dividend Ex-DateJul 02, 2024 Current Ratio2.15 EPS Y/Y TTM-6.88% Oper. Margin24.00% RSI (14)52.96 Volatility2.44% 2.10%
Employees18100 Debt/Eq0.47 Sales Y/Y TTM-6.38% Profit Margin18.84% Recom2.52 Target Price139.86
Option/ShortYes / Yes LT Debt/Eq0.37 EPS Q/Q3.38% Payout21.48% Rel Volume0.51 Prev Close136.06
Sales Surprise-0.56% EPS Surprise2.42% Sales Q/Q-8.39% EarningsMay 29 AMC Avg Volume1.99M Price133.50
SMA202.28% SMA50-2.83% SMA2001.53% Trades Volume1,031,195 Change-1.88%
Date Action Analyst Rating Change Price Target Change
Jul-10-24Upgrade Citigroup Neutral → Buy $135 → $150
Jun-27-24Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24Resumed Jefferies Hold $135
Apr-05-24Upgrade Stifel Hold → Buy $145 → $163
Dec-13-23Initiated Wolfe Research Outperform $140
Dec-12-23Downgrade BofA Securities Buy → Neutral $130 → $133
Nov-17-23Downgrade UBS Buy → Neutral $163 → $125
Sep-28-23Initiated Bernstein Mkt Perform $123
Jul-31-23Downgrade Evercore ISI Outperform → In-line $126 → $124
May-24-23Reiterated Wells Fargo Overweight $170 → $160
Jul-16-24 04:01PM
Jul-13-24 12:05PM
Jul-01-24 01:04PM
09:01AM
Jun-28-24 11:30AM
12:06PM Loading…
Jun-27-24 12:06PM
09:48AM
Jun-26-24 10:07AM
Jun-21-24 03:10AM
Jun-14-24 06:54AM
Jun-06-24 12:01PM
Jun-03-24 11:27AM
11:00AM
May-31-24 07:34PM
May-30-24 04:24PM
02:36PM Loading…
02:36PM
12:15PM
11:58AM
11:34AM
07:47AM
07:39AM
07:34AM
06:38AM
May-29-24 08:53PM
06:00PM
05:15PM
04:14PM
04:05PM
May-28-24 11:44AM
May-26-24 07:00AM
04:05PM Loading…
May-23-24 04:05PM
09:15AM
08:04AM
May-22-24 04:05PM
10:00AM
08:00AM
May-17-24 02:30PM
May-16-24 10:59AM
08:00AM
May-13-24 09:30AM
May-02-24 04:53PM
12:10PM
11:45AM
09:30AM
May-01-24 10:31AM
08:45AM
08:00AM
Apr-29-24 08:45AM
Apr-18-24 04:30PM
Apr-16-24 08:00AM
Apr-15-24 08:00AM
Apr-09-24 11:37PM
12:02PM
10:41AM
Apr-05-24 09:55AM
Apr-04-24 08:00AM
Apr-03-24 08:00AM
Apr-02-24 11:15AM
08:00AM
Apr-01-24 08:00AM
Mar-29-24 09:30AM
Mar-28-24 11:30AM
Mar-27-24 05:01PM
Mar-26-24 02:00AM
Mar-14-24 08:00AM
Mar-12-24 05:00PM
Mar-06-24 09:30AM
12:01AM
Mar-05-24 02:21PM
Mar-04-24 07:45PM
Feb-29-24 08:00AM
Feb-28-24 04:21PM
12:53PM
10:03AM
09:36AM
09:21AM
08:07AM
Feb-27-24 09:27PM
06:58PM
06:00PM
05:20PM
04:32PM
04:15PM
04:05PM
Feb-26-24 12:23PM
Feb-22-24 11:33AM
09:15AM
05:12AM
Feb-21-24 04:45PM
04:25PM
04:20PM
04:12PM
Feb-20-24 06:15PM
Feb-14-24 06:15PM
Feb-13-24 10:11AM
Feb-08-24 06:15PM
08:00AM
Feb-07-24 11:20AM
Feb-05-24 06:30AM
Feb-02-24 06:15PM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCDONNELL PADRAIGPresident and CEOJun 18 '24Sale135.001,958264,33028,034Jun 20 06:54 PM
Grau DominiqueSenior Vice PresidentJun 10 '24Sale133.2815,0001,999,26249,486Jun 12 10:40 AM
MCDONNELL PADRAIGPresident and CEOJun 03 '24Sale130.001,958254,54025,185Jun 05 10:08 AM
Binns PhilipSenior Vice PresidentMar 25 '24Sale147.542,827417,0969,997Mar 27 01:29 PM
McMullen Michael R.CEO and PresidentMar 08 '24Sale150.0052,2977,844,550253,909Mar 12 02:37 PM
Gonsalves RodneyV.P., Corporate ControllerMar 07 '24Sale149.004,828719,34821,329Mar 08 12:05 PM
FIELDS HEIDIDirectorMar 05 '24Sale144.341,658239,31654,976Mar 07 10:38 AM
Binns PhilipSenior Vice PresidentDec 27 '23Sale139.782,880402,56612,824Dec 28 01:46 PM
Gonsalves RodneyV.P., Corporate ControllerDec 18 '23Sale137.691,500206,53826,133Dec 19 02:34 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Option Exercise111.3611,7031,303,235108,835Dec 19 02:33 PM
Ancher-Jensen HenrikSr Vice PresidentDec 15 '23Sale138.3626,3313,643,15782,504Dec 19 02:33 PM
McMullen Michael R.CEO and PresidentDec 13 '23Option Exercise42.122,751115,872308,957Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 13 '23Sale130.002,751357,630306,206Dec 15 05:08 PM
McMullen Michael R.CEO and PresidentDec 07 '23Option Exercise42.1262,4672,631,110368,673Dec 08 02:59 PM
McMullen Michael R.CEO and PresidentDec 07 '23Sale130.0062,4678,120,710306,206Dec 08 02:59 PM
Gonsalves RodneyV.P., Corporate ControllerSep 28 '23Buy111.09328824,222Sep 29 04:03 PM
Gonsalves RodneyV.P., Corporate ControllerAug 23 '23Sale118.783,500415,71624,219Aug 25 12:53 PM
McMullen Michael R.CEO and PresidentJul 27 '23Option Exercise42.1294439,761261,813Jul 31 03:03 PM
McMullen Michael R.CEO and PresidentJul 27 '23Sale130.00944122,720260,869Jul 31 03:03 PM